Expression of CNN3 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

CNN3 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 506.35

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

735.1

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1783.3
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	1725.3
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	1535.5
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	1442.1
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1419.1
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1352.8
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	1319.0
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1290.6
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1281.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1244.4
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1196.2
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	1184.8
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1184.1
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1157.0
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1155.5
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	1130.5
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1119.4
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	1084.7
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	1077.4
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1040.0
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1036.9
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1032.7
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1029.3
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	1020.1
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	1008.3
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	995.6
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	992.1
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	981.5
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	971.4
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	968.6
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	968.2
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	937.0
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	932.3
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	925.2
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	900.0
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	887.7
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	882.8
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	880.3
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	862.3
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	858.2
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	856.0
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	842.7
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	841.5
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	839.5
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	831.1
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	810.5
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	810.2
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	788.0
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	780.8
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	773.6
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	768.5
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	767.8
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	764.3
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	757.7
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	754.2
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	753.9
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	744.0
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	742.3
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	733.3
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	731.4
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	730.8
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	726.8
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	723.4
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	721.6
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	719.0
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	699.5
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	699.1
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	684.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	678.1
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	672.0
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	665.8
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	664.4
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	659.0
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	651.1
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	648.0
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	637.9
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	636.8
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	634.0
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	632.1
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	629.4
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	626.8
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	624.7
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	624.7
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	624.5
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	621.6
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	617.6
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	614.7
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	610.0
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	607.3
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	597.0
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	592.0
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	589.8
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	587.3
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	585.5
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	580.4
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	576.7
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	556.0
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	552.8
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	550.1
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	550.0
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	549.6
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	545.1
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	539.1
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	525.7
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	525.3
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	520.7
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	519.5
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	512.2
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	507.8
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	506.9
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	506.3
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	504.3
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	495.8
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	487.5
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	473.4
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	473.2
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	470.6
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	462.9
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	458.5
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	453.5
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	453.5
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	449.0
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	445.6
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	441.8
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	439.2
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	419.2
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	417.1
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	412.1
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	404.5
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	404.3
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	392.4
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	367.0
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	365.6
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	342.8
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	313.7
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	312.2
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	303.7
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	303.1
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	275.4
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	257.7
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	206.2
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

CNN3 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1479.17

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1344.3

Number of samples

Samples

Sample	Description	pTPM
AK133	N, NA, stage:NA, dead, 360 days	2707.0
AK178	N, NA, stage:NA, dead, 240 days	2089.2
AK081	N, NA, stage:NA, dead, 180 days	2046.7
AK123	N, NA, stage:NA, dead, 180 days	2039.8
AK089	N, NA, stage:NA, dead, 330 days	2026.0
AK071	N, NA, stage:NA, dead, 540 days	2018.5
AK216	N, NA, stage:NA, dead, 360 days	2014.7
AK055	N, NA, stage:NA, dead, 240 days	1986.1
AK076	N, NA, stage:NA, alive, 660 days	1963.1
AK117	N, NA, stage:NA, dead, 210 days	1913.2
AK072	N, NA, stage:NA, dead, 150 days	1902.5
AK053	N, NA, stage:NA, dead, 300 days	1652.2
AK199	N, NA, stage:NA, alive, 1860 days	1642.6
AK236	N, NA, stage:NA, dead, 360 days	1636.9
AK231	N, NA, stage:NA, dead, 240 days	1558.3
AK099	N, NA, stage:NA, dead, 420 days	1522.6
AK156	N, NA, stage:NA, dead, 330 days	1480.2
AK098	N, NA, stage:NA, dead, 660 days	1478.2
AK124	N, NA, stage:NA, alive, 1920 days	1467.0
AK103	N, NA, stage:NA, alive, 1320 days	1466.2
AK183	N, NA, stage:NA, alive, 360 days	1461.4
AK142	N, NA, stage:NA, alive, 90 days	1433.2
AK074	N, NA, stage:NA, alive, 300 days	1424.3
AK100	N, NA, stage:NA, alive, 960 days	1417.4
AK005	N, NA, stage:NA, dead, 240 days	1408.7
AK068	N, NA, stage:NA, alive, 360 days	1358.1
AK158	N, NA, stage:NA, dead, 360 days	1350.6
AK006	N, NA, stage:NA, dead, 360 days	1332.0
AK051	N, NA, stage:NA, dead, 360 days	1330.2
AK218	N, NA, stage:NA, dead, 180 days	1313.8
AK041	N, NA, stage:NA, alive, 810 days	1291.5
AK030	N, NA, stage:NA, dead, 120 days	1290.5
AK153	N, NA, stage:NA, dead, 240 days	1278.7
AK167	N, NA, stage:NA, dead, 180 days	1267.0
AK091	N, NA, stage:NA, dead, 210 days	1266.0
AK003	N, NA, stage:NA, dead, 600 days	1265.0
AK213	N, NA, stage:NA, alive, 2010 days	1264.7
AK188	N, NA, stage:NA, alive, 420 days	1212.9
AK139	N, NA, stage:NA, dead, 270 days	1193.9
AK079	N, NA, stage:NA, dead, 210 days	1153.3
AK035	N, NA, stage:NA, dead, 210 days	1083.9
AK226	N, NA, stage:NA, dead, 360 days	1083.2
AK227	N, NA, stage:NA, alive, 300 days	1073.4
AK173	N, NA, stage:NA, dead, 180 days	1066.8
AK066	N, NA, stage:NA, alive, 960 days	1020.3
AK134	N, NA, stage:NA, dead, 360 days	1015.3
AK205	N, NA, stage:NA, dead, 120 days	998.8
AK049	N, NA, stage:NA, dead, 180 days	958.5
AK102	N, NA, stage:NA, alive, 1740 days	905.8
AK165	N, NA, stage:NA, alive, 360 days	844.2
AK088	N, NA, stage:NA, dead, 360 days	798.3
AK015	N, NA, stage:NA, alive, 720 days	798.0
AK085	N, NA, stage:NA, alive, 660 days	713.1
AK043	N, NA, stage:NA, alive, 660 days	701.1
AK149	N, NA, stage:NA, dead, 420 days	623.6
AK195	N, NA, stage:NA, dead, 390 days	546.1
AK185	N, NA, stage:NA, alive, 330 days	413.3
AK002	N, NA, stage:NA, dead, 570 days	406.5
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0002410011	Tumor	1.0
CPT0189460003	Tumor	0.7
CPT0093510003	Tumor	0.7
CPT0087570003	Tumor	0.7
CPT0167530003	Tumor	0.7
CPT0217190003	Tumor	0.6
CPT0217060003	Tumor	0.6
CPT0218890004	Tumor	0.6
CPT0168830003	Tumor	0.6
CPT0189850004	Tumor	0.6
CPT0225730003	Tumor	0.6
CPT0224390004	Tumor	0.5
CPT0087730003	Tumor	0.5
CPT0205780003	Tumor	0.5
CPT0218830004	Tumor	0.5
CPT0125220003	Tumor	0.5
CPT0127420003	Tumor	0.5
CPT0167640003	Tumor	0.4
CPT0190360004	Tumor	0.4
CPT0175060003	Tumor	0.4
CPT0079790003	Tumor	0.4
CPT0189570004	Tumor	0.4
CPT0221180003	Tumor	0.4
CPT0093590003	Tumor	0.4
CPT0206880003	Tumor	0.3
CPT0206000004	Tumor	0.3
CPT0093360003	Tumor	0.3
CPT0205570003	Tumor	0.3
CPT0087950003	Tumor	0.3
CPT0206780003	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0078580003	Tumor	0.2
CPT0127480003	Tumor	0.2
CPT0205450004	Tumor	0.2
CPT0206230003	Tumor	0.2
CPT0217880003	Tumor	0.2
CPT0217100003	Tumor	0.2
CPT0168270003	Tumor	0.1
CPT0217430008	Tumor	0.1
CPT0218670003	Tumor	0.1
CPT0201710003	Tumor	0.1
CPT0064890003	Tumor	0.1
CPT0161730003	Tumor	0.1
CPT0182500003	Tumor	0.0
CPT0206110003	Tumor	0.0
CPT0064650003	Tumor	0.0
CPT0167860004	Tumor	0.0
CPT0218960004	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0168480003	Tumor	-0.1
CPT0225760003	Tumor	-0.1
CPT0089150003	Tumor	-0.1
CPT0087680003	Tumor	-0.1
CPT0224330003	Tumor	-0.1
CPT0224600003	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0167750004	Tumor	-0.1
CPT0217710008	Tumor	-0.1
CPT0168590003	Tumor	-0.1
CPT0224540004	Tumor	-0.1
CPT0219080004	Tumor	-0.1
CPT0206450003	Tumor	-0.2
CPT0189650004	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0208980003	Tumor	-0.2
CPT0167970003	Tumor	-0.2
CPT0171580008	Tumor	-0.2
CPT0206670004	Tumor	-0.2
CPT0205670004	Tumor	-0.2
CPT0189250003	Tumor	-0.2
CPT0093550003	Tumor	-0.2
CPT0186100003	Tumor	-0.2
CPT0205890003	Tumor	-0.2
CPT0168380003	Tumor	-0.2
CPT0182580003	Tumor	-0.2
CPT0168720003	Tumor	-0.3
CPT0206330003	Tumor	-0.3
CPT0216920008	Tumor	-0.3
CPT0209440003	Tumor	-0.4
CPT0162140003	Tumor	-0.4
CPT0199770003	Tumor	-0.4
CPT0218770003	Tumor	-0.4
CPT0071100003	Tumor	-0.4
CPT0190240004	Tumor	-0.4
CPT0104220003	Tumor	-0.4
CPT0218690004	Tumor	-0.4
CPT0162020003	Tumor	-0.4
CPT0123530003	Tumor	-0.5
CPT0093450003	Tumor	-0.5
CPT0217000004	Tumor	-0.5
CPT0207030003	Tumor	-0.6
CPT0218330004	Tumor	-0.6
CPT0104330003	Tumor	-0.6
CPT0168080003	Tumor	-0.7
CPT0196850003	Tumor	-0.7
CPT0182550003	Tumor	-0.7
CPT0162100003	Tumor	-0.8
CPT0228220003	Tumor	-0.8
CPT0207090003	Tumor	-0.8
CPT0206560003	Tumor	-0.9
CPT0204370003	Normal	-1.2
CPT0204350003	Normal	-1.2
CPT0204380003	Normal	-1.3
CPT0204390003	Normal	-1.3
CPT0204360003	Normal	-1.4
CPT0204420003	Normal	-1.4
CPT0204340003	Normal	-1.5
CPT0204410003	Normal	-1.6
CPT0204330003	Normal	-1.7
CPT0204400003	Normal	-1.7
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA051237	Antibody CAB009849
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade